 Home > Biochemistry News > Biotechnology News > Oncolytic virus "guides" CAR-T therapy, cutting-edge partners join forces to explore new strategies for solid tumor treatment

Oncolytic virus "guides" CAR-T therapy, cutting-edge partners join forces to explore new strategies for solid tumor treatment

 Last Update: 2021-11-14
 Source: Internet
 Author: User

Tags

rous sarcoma virus

u2os cell line

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 1, 2021, Imugene announced that it has reached a strategic cooperation agreement with Eureka Therapeutics to evaluate Imugene's CD19-expressing oncolytic virus, combined with Eureka's CD19-targeted T cell therapy, and treat entities Tumor potential
.

The effect of CAR-T therapy on solid tumors is not ideal, and solid tumors account for about 90% of global tumors because it is difficult to find specific antigen targets on solid tumors
.

Oncolytic virus combined with T cell therapy represents a new method for the treatment of solid tumors

▲The principle of the combination of CD19-expressing oncolytic virus and CD19-targeting CAR-T therapy (picture source: Imugene's official website)

Reference materials:

[1] Imugene and Eureka Therapeutics Announce Strategic Collaboration to Accelerate Advancement of Oncolytic Virus and T-Cell Therapy in Solid Tumours.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.